miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients With Gastric Cancer

Gastroenterology Research and Practice - United States
doi 10.1155/2012/640168
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Is Lymph Node Size a Reliable Factor for Estimating Lymph Node Metastasis in Early Gastric Cancer?

Journal of Gastric Cancer
Cancer ResearchOncologyGastroenterology
2018English

A Nomogram to Predict Lymph Node Metastasis in Patients With Early Gastric Cancer

Oncotarget
Oncology
2017English

Clinicopathological Studies of Gastric Mucosal Cancer With Lymph Node Metastasis

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
1999English

Metastasis to Regional Lymph Node and Cellular Immunity of Gastric Cancer Patients

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1978English

Clinical Characteristics of Hepatoduodenal Lymph Node Metastasis in Gastric Cancer

World Journal of Gastroenterology
MedicineGastroenterology
2015English

A Rare Case of Lymph Node Metastasis From Early Gastric Cancer

Clinical Endoscopy
MedicineNuclear MedicineRadiologyImagingGastroenterology
2019English

High FOXP3+ Regulatory T-Cell Density in the Sentinel Lymph Node Is Associated With Downstream Non-Sentinel Lymph-Node Metastasis in Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Fine-Needle Aspirates CYFRA 21-1 Is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients

PLoS ONE
Multidisciplinary
2013English

Can We Predict Lymph Node Metastasis by Using Preoperative Markers in Gastric Cancer Patients?

Nowotwory
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy